First Time Loading...
B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 3.96 USD -0.75% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one BVS stock under the Base Case scenario is 16.34 USD. Compared to the current market price of 3.96 USD, Bioventus Inc is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BVS Relative Value
Base Case
16.34 USD
Undervaluation 76%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
63
vs Industry
79
Median 3Y
0.9
Median 5Y
0.9
Industry
2.4
Forward
0.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
23.2
Forward
-65.3
More Details
24.5
P/OCF
P/OCF
Price to OCF
24.5
vs History
41
vs Industry
17
Median 3Y
22.3
Median 5Y
22.3
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
2.3
Median 5Y
2.2
Industry
23.5
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
48
vs Industry
54
Median 3Y
1.5
Median 5Y
1.5
Industry
2.2
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
63
vs Industry
64
Median 3Y
1.6
Median 5Y
1.6
Industry
2.5
Forward
1.2
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
63
vs Industry
71
Median 3Y
2.3
Median 5Y
2.3
Industry
5.2
More Details
12.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.9
vs History
75
vs Industry
27
Median 3Y
16.5
Median 5Y
16.3
Industry
12.5
Forward
7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-14.4
Median 5Y
-12.8
Industry
17.2
Forward
14.3
More Details
58.6
EV/OCF
EV/OCF
Enterprise Value to OCF
58.6
vs History
17
vs Industry
5
Median 3Y
38.4
Median 5Y
35.5
Industry
15.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
9
Median 3Y
13.4
Median 5Y
6.7
Industry
19.7
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
51
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
2
More Details

Multiples Across Competitors

BVS Competitors Multiples
Bioventus Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bioventus Inc
NASDAQ:BVS
249.9m USD 0.5 -1.4 12.9 -27.4
JP
Hoya Corp
TSE:7741
6.4T JPY 8.5 38.3 23.2 28.7
CH
Alcon AG
SIX:ALC
35.1B CHF 4.1 39.6 17.7 35.9
DK
Coloplast A/S
CSE:COLO B
189.1B DKK 7.6 38.9 25.6 29.7
US
Align Technology Inc
NASDAQ:ALGN
21.6B USD 5.5 46.6 25.6 31.1
US
Cooper Companies Inc
NYSE:COO
17.8B USD 4.9 61.3 22.5 38.1
KR
HLB Inc
KOSDAQ:028300
13.8T KRW 322.4 -73.2 -119.2 -110
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.6B CNY 14.1 33.6 29.2 29.2
UK
ConvaTec Group PLC
LSE:CTEC
5.1B GBP 3 49.2 46.8 50.8
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -44.5 11.5 24.8
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD 4.1 16.4 12 13.9

See Also

Summary
BVS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BVS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BVS stock valuation using valuation multiples.
Wall Street Estimates
BVS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BVS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.